Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has sold MDX Hawaii, a wholly owned subsidiary, and its related operations to a private buyer. “This transaction will allow us to concentrate our efforts on our core partner markets, leveraging our proven, full-risk partnership model that enables physician groups to be accountable for the total cost and quality of care for thei.

agilon health Announces Sale of MDX Hawaii

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $107 million in gross savings (9.7% gross savings rate), including $24 million savings to the Medicare Trust Fund, during the 2022 performance year of the Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) model. agilon's eight REACH ACOs oper.

agilon health Reports ACO REACH Model Results for 2022 Performance Year

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2023 after the market closes on Thursday, November 2, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international.

agilon health Sets Date to Report Third Quarter 2023 Financial Results

agilon health expects positive adjusted EBITDA in 2023 and is experiencing double-digit net sales growth. The company's growth is driven by an increase in the number of members and partnerships with local physicians. Economies of scale, marketing efforts, and potential M&A could lead to significant free cash flow generation.

agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the following upcoming investor conferences. The 2023 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 6 at 11:00 AM Eastern Time. The Morgan Stanley 21st Annual Global Healthcare Conference, including a fireside chat presentation on Tuesday, September 12 at 8.

agilon health to Participate in Upcoming Investor Conferences

agilon health, inc. (NYSE:AGL ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Matthew Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Jailendra Singh - Truist Securities Stephen Baxter - Wells Fargo Securities Gary Taylor - Cowen Whit Mayo - Leerink Partners Adam Ron - Bank of America George Hill - Deutsche Bank Sandy Draper - Guggenheim Securities Jamie Perse - Goldman Sachs Elizabeth Anderson - Evercore ISI David Larsen - BTIG Operator Welcome to the agilon health Second Quarter 2023 Earnings Conference.

agilon health, inc. (AGL) Q2 2023 Earnings Call Transcript

Agilon Health (AGL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.04 per share a year ago.

Agilon Health (AGL) Reports Q2 Loss, Tops Revenue Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2023. “The durability and predictability of our partnership model enabled agilon to deliver strong performance during the second quarter and first half of 2023,” said Steve Sell, chief executive officer. “Our execution this year establishes a strong foundation for success in 2024 and beyond.

agilon health Reports Second Quarter 2023 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2023 after the market closes on Thursday, August 3, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +44 (208) 068-2558 for international.

agilon health Sets Date to Report Second Quarter 2023 Financial Results

agilon health has achieved its first quarter with over $1 billion in revenues, largely due to significant membership growth. AGL is taking strong steps to divert capital to buy back shares. The improvement in margins is necessary before the company could become a buy.

agilon health: A Hold Until Margins Are Improved

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Silvana Battaglia has been named as an independent board director. Battaglia brings more than two decades of business leadership experience in global human resources, shaping high-performance cultures, talent, and succession management, and driving organizational transformation within the pharmaceutical, healthcare and busin.

agilon health Names Silvana Battaglia to Board of Directors

PINEHURST, N.C.--(BUSINESS WIRE)--Pinehurst Medical Clinic (PMC), a recognized healthcare provider, and agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, have teamed up with COPE Health Solutions to expand the primary care, geriatric focused fellowship to Pinehurst, NC. The purpose of the fellowship is to continue to expand access to primary care by optimizing Advanced Practice Providers (APPs) in practice and further develop care.

Pinehurst Medical Clinic and agilon health Partner with COPE Health Solutions to Expand Primary Care Advanced Practice Provider (APP) Fellowship Program to North Carolina

Albemarle

Cal-Maine Foods

Norwegian Cruise Line

PPG Industries

Shoals Technologies Group

Vertex Energy

Valvoline

Warner Bros Discovery Inc

These are the growth stocks with the fastest EPS and revenue growth heading into June.

Top Growth Stocks for June 2023

Fintel reports that on May 31, 2023, Goldman Sachs maintained coverage of Agilon Health (NYSE:AGL) with a Buy recommendation.

Goldman Sachs Maintains Agilon Health Buy Recommendation

EVANS, Ga. & AUSTIN, Texas--(BUSINESS WIRE)--The Center for Primary Care (CPC), an independent practice dedicated to providing comprehensive preventative and specialized care, announced today it has formed a new partnership with agilon health inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, accelerating access to value-based primary care in the area. Starting in 2024 through the partnership, CPC will deliver this new model of primary care.

Center for Primary Care (CPC) Forms Long-term Partnership with agilon health, Bringing Value-Based Primary Care to the Central Savannah River Area (CSRA)

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 43rd Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 7, at 1:40PM Eastern Time. A simultaneous webcast for the event can be accessed by visiting the “Events & Presentations” section of agilon's Investor Relations website at https://investors.agilonhealth.com.

agilon health to Participate at 43rd Annual William Blair Growth Stock Conference

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL) (“agilon health”), the trusted partner empowering physicians to transform health care in our communities, today announced the pricing of its previously announced underwritten secondary public offering of 86,884,353 shares of its common stock by the selling stockholders, at a public offering price of $21.50 per share. Certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 7,726,955.

agilon health Announces Pricing of Secondary Offering

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the launch of an underwritten secondary public offering of 70,000,000 shares of its common stock by the selling stockholder, CD&R Vector Holdings, L.P., an affiliate of Clayton, Dubilier & Rice, LLC. The selling stockholder expects to grant the underwriters a 30-day option to purchase up to an additional 10,500,000 shares.

agilon health Announces Secondary Offering and Share Repurchase

agilon health, inc. (NYSE:AGL ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JPMorgan George Hill - Deutsche Bank Ryan Daniels - William Blair Justin Lake - Wolfe Research Carol Wong - Wells Fargo Securities Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Ben Mayo - SVB Securities Jamie Perse - Goldman Sachs Gary Taylor - Cowen David Larsen - BTIG Brian Tanquilut - Jefferies Operator Thank you all for joining.

agilon health, inc. (AGL) Q1 2023 Earnings Call Transcript

Agilon Health (AGL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.

Agilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2023. “Our successful start to 2023 reflects the dedication of our physician partners and the power of our network to consistently improve patient outcomes,” said Steve Sell, chief executive officer. “Our physician-centric model was designed to rapidly and efficiently scale across diverse p.

agilon health Reports First Quarter 2023 Results

PLANO, Texas & AUSTIN, Texas--(BUSINESS WIRE)--Catalyst Health Network, the largest clinically integrated network for independent primary care providers in Texas today, announced it has formed a long-term partnership with agilon health inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities. The partnership will bring agilon's value-based, Total Care Model to Catalyst's expansive primary care network and build upon Catalyst's proven model of relat.

Catalyst Health Network, Largest Network of Independent Primary Care Physicians in Texas, Forms Partnership with agilon health

Cano Health

Humana

Viatris

Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (AGL) and Cano Health (CANO).

4 Healthcare Stocks Poised to Beat Q1 Earnings Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S.

agilon health Sets Date to Report First Quarter 2023 Financial Results

agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's value proposition.

News for Agilon Health Stock (AGL)